Results 251 to 260 of about 182,514 (265)

Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes

Clinical and Experimental Immunology, 2020
Mark S Anderson, Young A
exaly  

Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy

Brain Communications, 2020
Shahar Shelly, James D Triplett, Marcus V Pinto   +2 more
exaly  

Overview of checkpoint inhibitor pneumonitis: incidence and associated risk factors

Expert Opinion on Drug Safety, 2021
Shuji Murakami, Terufumi Kato
exaly  

Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in Large Arteries

Circulation, 2020
Raffaella Calabretta, Christoph Hoeller, Verena Pichler   +2 more
exaly  

Interferon-Gamma–Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor–Colitis

Gastroenterology, 2021
Sarah C Sasson, Stephanie M Slevin, Eve Fryer   +2 more
exaly  

Impact of the corticosteroid indication and administration route on overall survival and the tumor response after immune checkpoint inhibitor initiation

Therapeutic Advances in Medical Oncology, 2021
Kamel Masmoudi, Youssef Bennis
exaly  

Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor–Associated Myocarditis

Journal of the American Heart Association, 2020
Zsófia Dora Drobni, Amna Zafar, Raza M Alvi   +2 more
exaly  

Effects of concomitant proton pump inhibitor use on immune checkpoint inhibitor efficacy among patients with advanced cancer

OncoImmunology, 2021
Bao-Dong Qin, Xiao-Dong Jiao, Bin Shi
exaly  

Dose dependence of treatment-related adverse events for immune checkpoint inhibitor therapies: a model-based meta-analysis

OncoImmunology, 2020
Boris Shulgin, Yuri Kosinsky, Andrey V Omelchenko   +2 more
exaly  

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells

Cell, 2018
Cecile Bonnafous, Ariane Morel, Benjamin Rossi   +2 more
exaly